1. Home
  2. CYTK vs FCN Comparison

CYTK vs FCN Comparison

Compare CYTK & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • FCN
  • Stock Information
  • Founded
  • CYTK 1997
  • FCN 1982
  • Country
  • CYTK United States
  • FCN United States
  • Employees
  • CYTK N/A
  • FCN N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • FCN Professional Services
  • Sector
  • CYTK Health Care
  • FCN Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • FCN Nasdaq
  • Market Cap
  • CYTK 5.6B
  • FCN 5.5B
  • IPO Year
  • CYTK 2004
  • FCN 1996
  • Fundamental
  • Price
  • CYTK $34.36
  • FCN $163.79
  • Analyst Decision
  • CYTK Buy
  • FCN Hold
  • Analyst Count
  • CYTK 14
  • FCN 2
  • Target Price
  • CYTK $70.92
  • FCN $175.50
  • AVG Volume (30 Days)
  • CYTK 1.4M
  • FCN 413.8K
  • Earning Date
  • CYTK 08-07-2025
  • FCN 07-24-2025
  • Dividend Yield
  • CYTK N/A
  • FCN N/A
  • EPS Growth
  • CYTK N/A
  • FCN N/A
  • EPS
  • CYTK N/A
  • FCN 7.32
  • Revenue
  • CYTK $19,218,000.00
  • FCN $3,668,381,000.00
  • Revenue This Year
  • CYTK $34.81
  • FCN $0.23
  • Revenue Next Year
  • CYTK $643.79
  • FCN $6.96
  • P/E Ratio
  • CYTK N/A
  • FCN $22.44
  • Revenue Growth
  • CYTK 412.21
  • FCN 1.59
  • 52 Week Low
  • CYTK $29.31
  • FCN $151.75
  • 52 Week High
  • CYTK $61.38
  • FCN $243.60
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 56.37
  • FCN 53.86
  • Support Level
  • CYTK $32.66
  • FCN $159.54
  • Resistance Level
  • CYTK $34.34
  • FCN $165.40
  • Average True Range (ATR)
  • CYTK 1.33
  • FCN 2.72
  • MACD
  • CYTK 0.21
  • FCN 0.41
  • Stochastic Oscillator
  • CYTK 76.45
  • FCN 77.13

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: